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Nanoparticle-cell interactions can promote cell toxicity and stimulate particular 
behavioural patterns, but cell responses to protein nanomaterials have been poorly 
studied. By repositioning oligomerization domains in a simple, modular self-
assembling protein platform, we have generated closely related but distinguishable 
homomeric nanoparticles. Composed by building blocks with modular domains 
arranged in different order, they share amino acid composition. These materials, once 
exposed to cultured cells, are differentially internalized in absence of toxicity and 
trigger distinctive cell adaptive responses, monitored by the emission of tubular 
filopodia and enhanced drug sensitivity. The capability to rapidly modulate such cell 
responses by conventional protein engineering reveals protein nanoparticles as 
tuneable, versatile and potent cell stressors for cell-targeted conditioning. 
 
Plain Language Summary 
Protein nanoparticles have been unexpectedly found as able to induce adaptive 
responses in exposed cells, involving morphological and functional changes, in 
absence of toxicity. These responses can be tuned by conventional protein 
engineering of the building blocks and adapted and exploited in the context of 
molecular therapies.  
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Proteins are gaining interest as safe and efficient biomaterials in different biomedical 
scenarios such as tissue engineering and drug delivery. In this context, nanoparticles, 
fibres, ribbons and 2D and 3D structures such as layers and hydrogel matrices are 
being recently developed. In contrast to metals, ceramics and polymers, whose 
biosafety and environmental impact might be controversial, proteins offer unique 
biocompatibility and full biodegradability, easy scalable bioproduction and high 
structural and functional versatility [1]. Being defined by the primary amino acid 
sequence, structure and function can be then modified by conventional genetic 
engineering. More than thirty years of experience in recombinant DNA technologies 
has offered more than 400 protein-based recombinant drugs approved for uses in 
humans by the medicines agencies [2] and hundreds of enzymes usable in different 
industries (food, textile, detergents, biofuel and paper, plus in chemical industry and 
for biomolecular research)[3]. In the last decades, many approaches have been 
explored to produce proteins as building blocks of complex supramolecular entities by 
engineering them as building blocks capable of self-assembling. This can be achieved 
by exploring natural oligomerization domains [4, 5] or by de novo designing molecular 
principles to promote very precise protein-protein interactions to build, for instance, 
cyclic structures, protein cages and others [6-9]. In this context, the combined use of 
a cationic domain at the amino terminus and a histidine-rich region at the carboxy 
terminus of a core protein (irrespective of the origin and amino acid sequences 
involved) has resulted in the generation of recombinant, protein-only cyclic 
nanoparticles ranging from 12 to 100 nm [10]. This category of materials has been 
demonstrated to be highly efficient as antimicrobial agents [11], as cell-targeted 
nanocarriers, drugs, and imaging agents in colorectal cancer [10, 12] and breast 
cancer [13] models and as blood-brain-barrier crossing vehicles [14].  
 
Despite the architectonic robustness and wide applicability of such three-module 
architectonic platform [15], how nanoscale architecture and functionalities of 
nanoparticles could be modulated by the repositioning of these structural agents has 
been so far unexplored. We have redesigned here a paradigmatic building block based 
on an amino terminal polyarginine tail (R9), an enhanced GFP and a carboxy-terminal 
histidine-rich region (H6) into structural and functional isoforms. Showing slightly 
different bio-physical properties, these materials, that share their amino acid 
composition, promote different adaptive responses in exposed mammalian cells. The 
sensitivity and morphological plasticity of mammalian cells to nanoscale protein 
materials observed here is discussed envisaging how protein nanoparticles can be 
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MATERIALS AND METHODS 
Protein production 
The three proteins used in this study were named according to the position of the 
peptides in the sequence (Figure 1A), and were all produced in Escherichia coli 
Rosetta (DE3). The parental protein R9-GFP-H6 has been previously described [16]. 
Two related protein constructions (H6-GFP-R9 and H6-R9-GFP) are modified versions 
that maintain the modular organization but with alternative order of peptides in the 
sequence. The encoding genes were designed in-house and were both supplied by 
Geneart (Germany) as E. coli codon-optimized genes. Upon insertion into pET22b 
(Novagen 69744-3), transformed bacteria were cultured in Lysogeny broth (LB) 
containing 34 g/ml chloramphenicol, 12.5 g/ml tetracycline (strain resistance) and 
100 g/ml ampicillin (vector resistance), at 37 ºC and at 250 rpm shaking until an 
OD550 of ~0.6 units. Then, gene expression was induced with 1 mM isopropyl-b-D-
thiogalactopyronaside (IPTG) and cells were cultured for 3 additional hours at 37 ºC 
and 250 rpm. After low speed centrifugation cells were resuspended in Wash buffer 
(20 mM Tris pH 8.0, 500 mM NaCl, 10 mM Imidazole) in the presence of EDTA-Free 
protease inhibitor cocktail (Complete EDTA-Free; Roche). R9-GFP-H6 expressing 
cells were further disrupted at 1200 Psi using a French Press (Thermo FA-078A). H6-
GFP-R9 and H6-R9-GFP expressing cells were washed with 20 mM Tris pH 7.2, 1 M 
NaCl, 10 mM Imidazole in the presence of EDTA-Free protease inhibitor cocktail, and 
disrupted by sonication. The soluble fractions were in all cases collected and filtered 
through 0.22 μm-filter, to be purified by single-step His-based affinity chromatography 
in HiTrap Chelating HP 1 ml column (GE Healthcare) on an ÄKTA purifier (GE 
Healthcare). Elution was achieved by a linear gradient up to 500 mM Imidazole in the 
corresponding Wash buffer of each protein. R9-GFP-H6 was dialysed overnight at 4 
ºC against Tris Dextrose buffer (20 mM Tris pH 7.4, 5 % dextrose), while H6-GFP-R9 
and H6-R9-GFP were dialysed against 20 mM Tris pH 7.2, 500 mM NaCl, 5 % dextrose. 
The purity of the proteins was determined by denaturing SDS-polyacrylamide gel 
electrophoresis (12 % polyacrylamide) and anti-6x-His-tag Western Blot and 
Bradford’s assays were performed to determine proteins’ concentration using Bovine 
Serum Albumin as standard. Protein production has been partially performed by the 
ICTS “NANBIOSIS”, more specifically by the Protein Production Platform of CIBER-
BBN/IBB at the UAB sePBioEs scientific-technical service 
(http://www.nanbiosis.es/unit/u1-protein-production-platform-ppp/) . 
 
Fluorescence determination and dynamic light scattering (DLS) 
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Specific fluorescence of proteins was determined in a Varian Cary Eclipse 
Fluorescence Spectrophotometer (Agilent Technologies) with all proteins being diluted 
to the same concentration (0.1 mg/ml). Samples were excited at a wavelength of 488 
nm and the emission detected in the range 500-548 nm, with maximum emission 
detected at 510 nm. Volume size distribution of nanoparticles and monomeric proteins 
were determined by DLS at 633 nm (Zetasizer Nano ZS, Malvern Instruments Limited). 
Measurements were performed in triplicate.  
 
Ultrastructural characterization 
Morphometry (size and shape) of representative nanoparticles at nearly native state 
was evaluated with a Field emission scanning electron microscope (FESEM) Zeiss 
Merlin (Zeiss) operating at 1 kV. Drops of 3 µl of proteins were directly deposited on 
silicon wafers (Ted Pella Inc.) for 1 min, the excess was blotted with Whatman filter 
paper number 1 (GE Healthcare), air dried, and immediately observed without coating 
with a high resolution in-lens secondary electron detector. On the other hand, two sets 
of HeLa cultures were incubated alone or exposed to each protein construct in 24-well 
plates on a coverglass, and evaluated at 2 h and 24 h. One set of samples was 
processed for Scanning electron microscopy (SEM) ultrastructural visualization 
following standard procedures for mammalian cell cultures [17]. Briefly, coverglasses 
with each sample were fixed in 2.5 % (v/v) glutaraldehyde (Merck) and 2 % 
paraformaldehyde (TAAB) in 0.1 M phosphate buffer (PB; Sigma-Aldrich) for 2 h at 4 
ºC, post-fixed in 1 % (w/v) osmium tetroxide (TAAB) containing 0.8 % (w/v) potassium 
hexocyanoferrate (Sigma-Aldrich) in PB for 2 h, and, then, dehydrated in graded series 
of ethanol, dried with CO2 in a Bal-Tec CPD030 critical-point dryer (Balzers), mounted 
in stubs, coated with Pt-C, and observed in a SEM Zeiss EVO equipped with a 
secondary electron (SE) detector and operating at 15 kV. For the quantitative approach 
of morphological changes, SE images of randomly selected fields were captured and 
the percentage of cells with long filopodia (higher than the cell diameter) was 
calculated for each 24 h samples. The other set of samples was processed for FESEM 
immunolocalization visualization following standard procedures for gold labelling of 
mammalian cell cultures [18]. Briefly, coverglasses with each sample were fixed in 4 % 
paraformaldehyde (TAAB) in 0.1M PB (Sigma-Aldrich) for 30 min at 4 ºC, rinsed with 
0.1 M PB and then placed in blocking buffer PBS- 1 % BSA (Sigma-Aldrich) containing 
20 mM glycine (Merck), incubated overnight in a rabbit polyclonal anti-GFP primary 
antibody (ab-6556, dilution 1:25; Abcam) at 4 ºC, rinsed with PBS-BSA, incubated in 
protein A coupled to 20-nm gold particles (dilution 1:50; BBI) for 1 h at room 
temperature, rinsed with PBS and with water, and, then, dehydrated in graded series 
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of ethanol, dried with CO2 in a Bal-Tec CPD030 critical-point dryer (Balzers), mounted 
in stubs, and observed without coating in a FESEM Zeiss Merlin operating at 1.4 kV 
and equipped with a secondary electron detector and an energy selective back-
scattered electron (BSE) detector. For the quantitative approach of labelling, BSE 
images at same conditions (Mag: 60,000x, WD: 3 mm) of five different randomly 
selected fields of each 24 h sample were processed using Image J software (NIH 
Image). 
 
Cell culture and internalization 
In vitro experiments were performed on HeLa cells (ATCC-CCL-2) cultured in MEM-
alpha (Gibco) supplemented with 10 % Foetal Calf Serum (Gibco) and incubated at 
37ºC and 5 % CO2. Internalization assays were performed in triplicate, in 24-well plates 
with the medium being replaced by serum-free OptiPro supplemented with L-
Glutamine before the addition of the proteins. After incubation (2 h or 24 h, with varying 
concentrations of proteins as indicated in each case), a harsh treatment with trypsin 
was performed (Trypsin (Gibco), at 1 mg/ml for 15 min) to remove proteins bound to 
the surface of the cells. Internalization was analysed by flow cytometry on a FACS 
Canto (Becton Dickinson), with fluorescence excited using a 15 mW air-cooled argon 
ion laser at 488 nm and detected by a 530/30 nm band pass filter D detector. All 
internalization results were corrected with the fluorescence values obtained by 
fluorometry to render data comparable in terms of protein mass. To assess the level 
of involvement of CXCR4 receptors in internalization, competition assays were 
performed with HeLa cells pre-incubated for 1 h with the specific antagonist AMD3100 
(octahydrochloride hydrate, Sigma-Aldrich), which was added to fresh OptiPRO 
medium to a final concentration of 10 μM (corresponding to 1:10 molar ratio 
protein:antagonist).  
 
Cell viability assays 
The potential toxicity of proteins was determined in HeLa cells cultured on 96-well 
Optical-Bottom plates with polymer base (Thermo Fisher Scientific) at 5,000 cells/well 
with 90 μl of MEM alpha medium with serum, for 24 h. Proteins prepared in 10 μl of 
medium for a final concentration of 1 μM or 2 μM were added to each well, and 
incubated for 2 h or 24 h. Then, cell viability was determined by CellTiter-
GloLuminiscent Cell Viability Assay (Promega), by adding 100 μl of the reagent in each 
well. Luminescence was measured with Victor3 (PerkinElmer) according to the 
following program: 2 min of orbital shaking to induce cell lysis and 10 min of incubation 
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at RT to stabilize the luminescent signal, that was finally measured at 0.2 s, 0.5 s and 
1 s.  
 
The cell proliferation assay EZ4U (Biomedica) was used to determine the sensitivity of 
HeLa cells to cisplatin, after pre-conditioning with protein nanoparticles. Cells were 
cultured in a 96-well plate at 3,500 cells/well during 24 h at 37 ºC until reaching 70 % 
confluence. R9-GFP-H6 and H6-GFP-R9 nanoparticles were then added for 24 h at 
37ºC to a final concentration of 2 µM. Then, the cytotoxic drug cisplatin (Sigma-Aldrich) 
was added at 40 µM and 65 µM for 24 h at 37 ºC. Finally, 20 µl of the assay substrate 
were added at 37ºC for 3 h and the absorbance was measured by a microplate-reader 
set at 450 nm with 620 nm as a background reference. All cell viability analyses were 
performed in triplicate. 
 
Confocal microscopy 
HeLa cells were grown on Mat-Tek plates (MatTek Corporation). The medium was 
replaced by serum-free OptiPro supplemented with L-Glutamine, followed by the 
addition of proteins to a final concentration of 1 µM or 2 µM, and further incubation for 
2 h or 24 h before being washed in PBS buffer (Sigma-Aldrich). The nuclei were 
labelled with 10 µg/ml Hoechst 33342 (Invitrogen) and the plasma membrane with 2.5 
µg/ml CellMaskTMDeep Red (Molecular Probes) for 10 min at RT and then washed in 
PBS buffer (Sigma-Aldrich). Living cells were recorded by TCS-SP5 confocal laser 
microscopy (Leica Microsystems) using a Plan Apo 63x/1.4 (oil HC x PL APO lambda 
blue) objective. Hoechst 33342 DNA label was excited with a blue diode (405 nm) and 
detected in the 415–460 nm range. GFP-proteins were excited with an Ar laser (488 
nm) and detected in the 525–545 nm range. CellMask was excited with a HeNe laser 
(633 nm) and detected in the 650–775 nm range. To determine the protein localization 
inside the cell, stacks of 20–30 sections were collected with 0.5 μm of thickness, and 
3D models were generated using Imaris software (Bitplane). Experiments were 
performed in quintuplicate, evaluating 4 fields of each experiment in 3D.  
 
Statistical analysis 
Values are expressed as mean data and standard error. Multiple comparisons were 
performed by one-way ANOVA with Tukey test or Kruskall-Wallis H-tests and pairwise 
comparisons by two-tailed Student t-tests or Mann-Whitney U-tests using Microsoft 






R9-GFP-H6, H6-GFP-R9 and H6-R9-GFP (Figure 1A) were successfully produced in 
E. coli as single protein species with the expected molecular mass of 30 kDa, a fact 
that was confirmed by conventional PAGE followed by ComassieBlue staining and 
Western Blot (Figure 1B). The observation of single bands was indicative of absence 
of important proteolysis. Upon successful purification by one step His-based affinity 
chromatography, all the proteins resulted fluorescent, proving a correct conformation 
of the GFP fluorophore and allowing the further monitoring of the materials in complex 
media. Noticeably, R9-GFP-H6 exhibited a slightly higher specific emission than its 
counterparts (Figure 1C). As previously demonstrated for R9-GFP-H6 [16], H6-GFP-
R9 and H6-R9-GFP also self-assembled as nanostructures (Figure 1 D, Figure 2), with 
larger peak sizes and slightly wider size dispersion (59 nm and 79 nm, versus 28 nm 
in the case of R9-GFP-H6). As determined by FESEM, all the materials organized as 
regular nanoparticles with distinguishable and well defined toroid-like morphologies 
(Figure 2), confirming the sizes of the particles determined by DLS. In this regard, both 
DLS and FESEM have been recently observed as very robust analytical tools to 
precisely examine the nanoscale structure of protein-based assemblies, offering data 
fully coincident with more sophisticated methodologies such as SAXS, AFM, TEM 
(negative staining and Pt evaporation), and cryoTEM [10, 15, 16, 19]. H6-GFP-R9 and 
H6-R9-GFP were within the particle size ranges optimal for cell internalization [20] and 
also matching those reported to elicit cell responses [20]. R9-GFP-H6 was slightly 
below these effective reported sizes, although it has been previously shown that it 




Figure 1. Biological production or protein building blocks and physical characterization of 
the resulting nanoparticles. A. Modular organization of R9-GFP-H6, H6-GFP-R9 and H6-R9-
GFP (from top to bottom). A linker sequence (GGGNS) was always present at the amino 
terminus of GFP separating it from the previous module. B. Comassie Blue staining (CB) and 
Western blot (WB) of R9-GFP-H6, H6-GFP-R9 and H6-R9-GFP upon purification. Figures 
indicate the molecular masses of relevant markers (M) in kDa. C. Fluorescence emission 
spectra of purified R9-GFP-H6, H6-GFP-R9 and H6-R9-GFP, with all samples at the same 
concentration (0.1 mg/ml). D. Volume distribution analysis of R9-GFP-H6, H6-GFP-R9 and H6-






Figure 2. Morphometric analysis of protein nanoparticles. Representative FESEM imaging of 
ultrastructure (size and shape) of R9-GFP-H6, H6-GFP-R9 and H6-R9-GFP nanoparticles at 




Apart from its role as promoter of nanoparticle formation [16], R9 is a potent cell-
penetrating peptide (CPP) that has been largely used in non-viral gene or protein 
therapies to mediate internalization of cargo drugs [22]. R9 might also have a residual 
receptor-specific penetrability through its interaction with the cytokine receptor CXCR4 
[23], that is clinically relevant as a co-receptor of the human immunodeficiency virus 
[24] and also as a tumor marker overexpressed in several human cancers [25]. 
Internalization of the variant nanoparticles was then explored in cultured CXCR4+ HeLa 
cells to investigate the effects that the R9 positioning in the modular constructs might 
have on R9-mediated cell penetrability. Interestingly, while all the material isoforms 
penetrated cells, the amount of internalized H6-GFP-R9 was 10 fold higher (and 
statistically significant) than that achieved by R9-GFP-H6 and H6-R9-GFP, as 
observed at both 2 h and 24 h of exposure to cells (Figure 3A). A dose-dependent 
penetration was evident and significant in all cases, but more consistently observed in 
poorly penetrating materials. To test the potential specificity mediating nanoparticle 
penetration, we used a chemical antagonist of CXCR4, namely AMD3100 [26], that 
blocks the interaction of the receptor with external ligands. This competitor significantly 
reduced the internalization of both R9-GFP-H6 and H6-R9-GFP at two tested doses, 
while it did not show negative effect on the uptake of H6-GFP-R9 (Figure 3B). This fact 
indicates an important extent of CXCR4-mediated cell penetrability of R9-GFP-H6 and 
H6-R9-GFP, while the uptake of H6-GFP-R9 relies mostly on mechanisms irrespective 
of CXCR4. Therefore, the free carboxy terminus of R9 as accommodated in H6-GFP-
R9 mediates a dramatic enhancement of the uptake efficiency probably linked to the 
polyarginine acting as a true CPP, devoid of any specificity in the interaction with cells. 
In this context, it must be noted that at high concentrations of this protein and upon 
long exposure times, AMD3100, blocking CXCR4 binding, seems to favour a more 
efficient cell penetration by CXCR4-independent ways, probably through the CPP 
properties of R9 (Figure 3 B). Both events, cell penetrability and lack of specificity are 
apparently connected, since CXCR4-dependence is gained in nanoparticles with R9 
in positions alternative to the carboxy terminus. Differential and enhanced cell 
penetration of H6-GFP-R9 was fully confirmed by confocal microscopy and by 
comparative analyses of internalized fluorescence (Figure 4A). In all treated cell 
cultures, a similar cell density, cell size and shape were observed. However, H6-GFP-
R9 exposed cells, specially upon 24 h of exposure, showed abundant intracellular 
accumulation of fluorescence (Figure 4, B-D). Because of the high green intensity 
shown in such conventional confocal sections of the highly penetrating nanoparticle 
we performed further analysis and 3D reconstructions to better explore the occurrence 
and status of the intracellular protein. As observed (Figure 4B, D), the H6-GFP-R9 
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partially appeared as rod-shaped or tubular structures that might be due to longitudinal 
staking of toroid nanoparticles (as previously observed for R9-GFP-H6 under specific 
conditions such as the presence of DNA [27]), or to a particular organization of cellular 
membranes to which fluorescent material is associated. Shorter exposures (2 hours) 
were valuated (Figure 4D), where proteins highly colocalize with cell membrane, and 
elongated filopodia can be observed associated with proteins. The 3D reconstruction 
(Figure 4E) shows protein distribution. In figures 4E and 4F we can observe that under 
the same conditions the proteins R9-GFP-H6 and H6-R9-GFP, respectively, have an 
inferior penetration capacity, occurring as dots but never as elongated structures. The 
penetrability of the materials was not, in any case, linked to cytotoxicity, as exposed 
cells did not show any significant decrease in cell viability (Figure 4H). No important 
aggregation could be associated to H6-GFP-R9 as no large fluorescent clusters were 
apparent in the extracellular media. Although from these images it was not possible to 
precisely discriminate between intra and extracellular localization of these fibrils, most 
of the recorded fluorescence was indeed intracellular (Figure 4A).  
 
 
Figure 3. Cell penetrability of protein nanoparticles. A. Intracellular fluorescence after 2 
hours and 24 hours of exposure of cultured HeLa cells to different amounts of protein 
nanoparticles. Intracellular fluorescence was recorded after a harsh trypsin treatment to fully 
remove externally retained signal [28], and the records were corrected by the specific 
fluorescence of the protein variants (Figure 1C) to allow mass-based comparisons. Statistics 
are ** p<0.001; * p<0.05. Pairwise comparisons between R9-GFP-H6 and H6-GFP-R9, and 
between H6-GFP-R9 and H6-R9-GFP always resulted significant for any tested dose (always **, 
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at exception of 1000 mM and 24 h, that resulted in *). Comparisons between R9-GFP-H6 and 
H6-R9-GFP resulted always not significant for any tested dose. B. AMD3100 (AMD)-mediated 









Figure 4. Internalization and intracelular localization of protein nanoparticles. A. 
Intracellular comparative profiling of green fluorescence (green lines) associated to 
nanoparticles in longitudinal confocal sections of exposed HeLa cells. The red line indicates 
the cell membrane intensity. In the insets, representative confocal images of the cultures 2h 
upon protein addition. B. Orthogonal views of the image volume of cells exposed to H6-GFP-
R9 for 24 h, showing longitudinal fluorescent strips, some of which appeared inside the cell 
(white arrow). The blue and red signals correspond to nuclear and cell membrane labeling, 
respectively. C. Colocalization (yellowish merging of green and red signals) between the 
tubular proteins H6-GFP-R9 with the membrane filopodia. D. Imaris 3D reconstruction of the 
half volume of the cells shows the protein H6-GFP-R9 inside the cytoplasm. E-F. Orthogonal 
views of image volumes from R9-GFP-H6 and H6-R9-GFP, respectively. Protein constructs 
appeared as globular structures and show inferior penetration capacity inside the cell. G. 
MTT-mediated analysis of HeLa cell viability upon exposure to 1 and 2 µm nanoparticles for 
2h in solid bars and 24 h in dashed bars. A Mann-Whitney test revealed non-significant 




Figure 5. SEM analysis of cells exposed to nanoparticles. Representative SEM images of 
mammalian HeLa cells ultrastructure once incubated alone (control) or exposed to the three 




Because of the observed particular fluorescence pattern, (Figure 4B), we decided to 
explore the ultrastructural morphology of nanoparticle-exposed cells by combining 
FESEM (SE), labelling of GFP (by quantification of gold particles from a secondary 
antibody -BSE-), and the localization of GFP labelling combined with morphometric 
data (SE+BSE). As observed (Figure 5), there was a dramatic increase in number and 
length of tubular membranous structures or filopodia (with diameters within the 
nanoscale) in HeLa cells upon contact with H6-GFP-R9 nanoparticles, especially after 
24 h exposure (39.2 % of cells with filopodia lengths comparable to the cell diameter; 
n=56), but not in cultures exposed to alternative modular constructions (0 % in both 
cases; n=50). The absence of significant cell toxicity in any treatment (Figures 4H and 
5) excluded the occurrence of cell-death pathways while prompted to speculate about 
the stimulation of cell sensing activities promoted by H6-GFP-R9. Interestingly, the 
analysis of protein immunolocalization by FESEM in exposed HeLa cells indicated the 
presence of external nanoparticles closely associated to tubular membrane structures, 
which is more apparent in the case of H6-GFP-R9.The heavy coating of filopodia with 
H6-GFP-R9 might be linked to the fibrilar fluorescent structures shown in Figure 4B. 
However, the high intracellular fluorescence emission of H6-GFP-R9-exposed cells 
(Figure 3, 4A) seemed to indicate that an important part of such fluorescent biomaterial 






Figure 6: FESEM analysis of nanoparticles localization in cell surface. A. Representative 
FESEM images of nanoparticles localization at nanoscale in mammalian HeLa cells surface 
after incubation alone (control) or exposed 24 h to the three different constructs. Bars represent 
200 nm. SE: secondary electron detection; BSE: energy selective back-scattered electron 





The formation of membranous tubes of 50-200 nm of diameter and up to several cell 
diameters long had been already described [29]. They might be derived from 
conventional filopodia and often contain F-actin [30]. Importantly, these membranous 
structures seem to be involved in molecular, electrical and mechanical signalling as 
well as in developmental processes [30]. In addition, they participate in the intercellular 
transfer of cellular components and are used by viruses and prions to spread between 
cells [30]. To investigate if transfer of substances might be affected in filopodia-emitting 
cells once stimulated by H6-GFP-R9 nanoparticles we evaluated the cytotoxic effect 
of cisplatin, to which normal cells are partially permeable. As observed, nanoparticle 
exposure moderately but significantly enhanced cell death mediated by this drug, at 
two different tested doses (Figure 7). This fact indicates that the cell-stressing effect 
of H6-GFP-R9 nanoparticles has a physiological counterpart beyond the mere 




Figure 7. Cell sensitivity to different doses of cisplatin upon pre-conditioning R9-GFP-H6 or 










Physicochemical properties of nanoparticles such as size, shape, superficial charge 
and chemical composition determine the intricacy of material-cell interactions and the 
biological effects on exposed cells, including toxicity [31-34]. Less studied than toxicity, 
a spectrum of adaptive cell responses and compensatory systemic responses is 
triggered upon exposure to nanostructured materials [35], that might follow non-lineal, 
hormetic dose-response patterns [35, 36]. Systemic stress in response to nanoparticle 
exposure has been also reported, including increase of plasmatic cortisol levels [37] 
and stress hormones [38], autophagy [39], oxidative stress [40] and enhanced 
expression of apoptosis-related genes [41]. Nanostructured materials can be then 
observed as a category of cellular and organic stressors, whose biological effects are 
ultimately linked to their intrinsic toxicity [39, 42-44]. Most of these toxicity studies have 
been performed with metal nanoparticles, but toxicity and potential stress responses 
triggered by protein nanoparticles remain unexplored, despite of the emerging interest 
in this category of materials.  
 
Regular protein-only nanoparticles are under fast development pushed by emerging 
rational and semi-rational principles to control self-assembly[5, 7, 9, 45], and among 
other applications they are appealing as virus-like mimetics for intracellular drug 
delivery [46]. In addition, protein-based nanomaterials benefit from easy biological 
fabrication and from the capability to recruit a diversity of functions relevant to drug 
delivery such as self-assembling, cell targeting, endosomal escape and nuclear 
transport in their building blocks [47]. Here we have produced and characterized, 
regarding architecture and function, closely related homomeric nanoparticles designed 
by repositioning oligomerization domains (R9 and H6) in self-assembling, modular 
polypeptides (Figure 1). By this, morphometrically distinguishable nanoparticles have 
been generated (Figure 2) that differentially penetrate cultured cells (Figure 3). In a 
particular domain distribution, in which R9 is placed at the carboxy terminus of the 
building block (H6-GFP-R9), nanoparticles show a dramatically enhanced cell 
penetrability associated to the CPP properties of R9 (Figure 3). In alternative modular 
distributions (R9-GFP-H6 and H6-R9-GFP), nanoparticles penetrate target cells by a 
combination of CXCR4-independent (CPP-based) and CXCR4-dependent 
internalization mechanisms (Figure 3). Therefore, the precise position of R9 may either 
favour or impair the display accessibility of this peptide to interact with the receptor 




Interestingly, the exposure to cultured cells to these materials, that share amino acid 
composition but show distinct nanoparticle size (indicative of different oligomeric 
complexity [15]), trigger differential emission of long tubular filopodia (Figure 5), that is 
especially intense in the case of the highly penetrating H6-GFP-R9 nanoparticles 
(Figure 3). Filopodia are actin-rich membrane emissions occurring in adaptive cell 
responses, which linked to stress fibres [48] serve cells to probe extracellular media. 
They also have pivotal roles in migration [49], neuronal differentiation and in tissue 
regeneration [50]. The particular formation of the membranous structures observed 
here (long tubules with nanoscale diameters) is mediated by the Ral-exocyst pathway 
[51] and is involved in intercellular transfer of materials, including viruses and prions 
[30].The localization of H6-GFP-R9 nanoparticles on these membranous emissions 
(Figure 6) reinforces the idea that the emission of filopodia occurs as a response to 
nanoparticle exposure and that protein nanoparticles act as cell stressors. This effect 
occurs by mechanisms that unlike metal nanoparticles, are fully unlinked to cell toxicity 
(Figure 4G) and might be related to the interaction between nanoparticles and plasma 
membrane that regulate CPP-mediated engulfment (Figure 3). The precise 
mechanisms by which H6-GFP-R9 nanoparticles stimulate filopodia emission are not 
known, although it is unlikely that they would be solely based on the material size. The 
size variation of the nanoparticle set studied here is within relatively narrow margins in 
which such response has not been previously described for biologically inert materials 
[20]. This fact suggests a position-dependent involvement of biologically active protein 
domains, such as R9. Interestingly cells emitting more and longer filopodia are those 
more sensitive when exposed to cisplatin (Figure 7). This might indicate a physiological 
connection between membrane morphology (determining the cell surface area) and 
drug penetrability, although a higher drug sensitivity of H6-GFP-R9-exposed cells, due 
to inner stress mechanisms cannot be fully discarded. Among other potential 
applications, this effect might be considered to amplify drug effects through previous 
cell pre-conditioning, which might be in addition targeted to cell surface tumor markers 
by empowering the nanoparticles with specific ligands of these markers. Since protein 
corona is not formed over protein nanoparticles, the in vivo tumor targeting of these 
materials once empowered by short peptide ligands is extremely precise [19].   
 
Different extent of filopodia formation is achieved by members of the nanoparticle set, 
which differ from each other by mere modular organization of the building blocks. 
Therefore,  irrespective of the precise underlying mechanisms, simple protein 
engineering can convert irrelevant nanoparticles such as R9-GFP-H6 into potent 
inducers of cell responses like H6-GFP-R9. This is probably related to an enhanced 
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membrane activity of R9 when showing a free carboxy terminus, maybe combined with 
an optimal material size. According to our data, nanoparticle-conditioned cells might 
be more permeable and/or more sensitive to external substances that, like cisplatin, 
might have a therapeutic applicability. The development of non-toxic cell stressors 
based on self-assembling proteins (that can be easily produced in food-grade 
bacterian absence of endotoxin contaminants [52]) can be further improved by cell 
targeting,reachable by the incorporation of specific cell surface ligands. These 
nanostructured biomaterials can then activate adaptive responses in target cells. This 
possibility points out protein nanoparticles (fully tuneable by genetic engineering) into 
appealing instruments in regenerative medicine, in cell-targeted therapies, and more 




The relative position of R9 and H6 domains in GFP fusions impacts on the specific 
fluorescence emission of the modular polypeptides and on their ability to self-assemble 
as oligomeric nanoparticles.  
The modular organization R9-GFP-H6 results in highly fluorescent 27 nm-
nanoparticles, while H6-GFP-R9 and H6-R9-GFP assemble in less fluorescent, larger 
materials.  
Penetrability of the oligomers in cultured cells, mediated by R9, is dramatically 
enhanced in the disposition H6-GFP-R9, regarding the alternative modular 
organizations. Cell penetrability of H6-GFP-R9 nanoparticles occurs irrespective of the 
cell receptor CXCR4 (at least at early exposure times), to which R9 has been proved 
to bind. 
H6-R9-GFP but not the other tested protein variants stimulates, in exposed HeLa cells, 
an abundant emission of long and tubular filopodia in absence of detectable 
cytotoxicity. 
In H6-GFP-R9-exposed cells, cisplatin is more cytotoxic than in cells exposed to other 
protein variants, by mechanisms that might involve enhanced drug penetrability and/or 
enhanced drug sensitivity. 
Promoting protein oligomerization of protein nanoparticles by cationic and histidine-
rich domain engineering allows the production of closely related protein materials but 
showing fully distinguishable biological activities.  
By alternating the domain position in protein nanoparticles with the same amino acid 
composition it is possible to control adaptive cells responses. These protein materials 
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might be of interest as pre-conditioning agents in molecular therapy, regenerative 
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